CN Patent

CN111032048B — 丁螺环酮用于治疗功能性头晕的用途

Assigned to Valenta Intellect LLC · Expires 2023-04-04 · 3y expired

What this patent protects

本发明涉及医学和药理学领域，并且，具体地涉及丁螺环酮或其药学上可接受的盐用于治疗功能性头晕、持续性体位‑感知性头晕(PPPD)、恐惧性体位眩晕(PPV)和慢性主观头晕(CSD)的新用途，本发明的效果在于治疗独立于抑郁和焦虑状态的功能性头晕的可能性，临床上治疗作用起效的最佳速度，易于剂量滴定，无镇静作用，以及良好的安全性。

USPTO Abstract

本发明涉及医学和药理学领域，并且，具体地涉及丁螺环酮或其药学上可接受的盐用于治疗功能性头晕、持续性体位‑感知性头晕(PPPD)、恐惧性体位眩晕(PPV)和慢性主观头晕(CSD)的新用途，本发明的效果在于治疗独立于抑郁和焦虑状态的功能性头晕的可能性，临床上治疗作用起效的最佳速度，易于剂量滴定，无镇静作用，以及良好的安全性。

Drugs covered by this patent

lumateperone-tosylate (LUMATEPERONE TOSYLATE)

Patent Metadata

Patent number: CN111032048B
Jurisdiction: CN
Classification: —
Expires: 2023-04-04
Drug substance claim: No
Drug product claim: No
Assignee: Valenta Intellect LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.